Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX7G2K
|
||||
| Drug Name |
(S)-N-(3-(3-chlorophenyl)-1-(cyanomethylamino)-1-oxopropan-2-yl)cycloheptanecarboxamide
|
||||
| Synonyms |
CHEMBL550247
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H24ClN3O2
|
||||
| Canonical SMILES |
Clc1cccc(C[C@H](NC(=O)C2CCCCCC2)C(=O)NCC#N)c1
|
||||
| InChI |
InChI=1S/C19H24ClN3O2/c20-16-9-5-6-14(12-16)13-17(19(25)22-11-10-21)23-18(24)15-7-3-1-2-4-8-15/h5-6,9,12,15,17H,1-4,7-8,11,13H2,(H,22,25)(H,23,24)/t17-/m0/s1
|
||||
| InChIKey |
LOYNXKUDTAAJJS-KRWDZBQOSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.